Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


DETERMINATION OF IN-VITRO EQUIVALENCE OF BCS CLASS 1 DRUGS: PARACETAMOL, PHENOXYMETHYLPENICILLIN AND METRONIDAZOLE TABLETS AVAILABLE IN SRI LANKA

  • In: C5 - Short oral presentations – focus on science & industry on Wednesday, 30 September 2015, 14:30-17:30
  • At: Düsseldorf (Germany) (2015)
  • Type: Presentation
  • By: THAMBAVITA, Dhanusha (Faculty of Medicine, University of Colombo, Pharmacology, Colombo-08, Sri Lanka)
  • Co-author(s): Dhanusha Thambavita
  • Abstract:

    Biopharmaceutics Classification System(BCS) based biowaiver(BW) studies are acceptable  for determining  bioequvalance(BE) of drugs belonging to BCS class I and some class III Drug regulatory authority(DRA) of Sri Lanka(SL) currently does not use BW criteria in generic drug registration. 

     

    Panadol(GSK), Ospen(Sandoz) and Flagyl(Sanofi) were used as

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses